IBM And ADA Collaboration

The American cloud computing company partners with the Association to develop tools for helping diabetes patients and their caregivers

IBM Watson Health has collaborated with American Diabetes Association to integrate artificial intelligence in research. The duo intends to develop healthcare providers and diabetes advisor for patients based upon the Association’s repository of research and clinical data, in addition, they’re giving a challenge to cognitive computing-based application developers to enhance diabetes management and prevention.

In recent times, Watson Health signed a similar kind of agreement with the American Cancer Society, intended to better advise oncology patients as well as their providers based upon the AI system’s ACS information analysis. And it has also signed a series of agreements for the application of cognitive computation to clinical trials as well as oncology genomics data.

The ADA venture intends to meet the needs of 3 main groups:  patients and caregivers, researchers and healthcare providers. It’s designated to enable the cognitive diabetes database development to guide healthcare treatment decision as well as the research database population health management and tools, which can offer personalized details depending upon a number of variables. These include treatment regimen, disease stage, behaviors and demographics.

Population health management is a research database designed to elicit concealed patterns for guiding therapeutic discovery.  CEO of ADA Kevin Hagan stated . "By combining the Association's enormous body of valuable data with Watson's cognitive computing capabilities, we will empower people living with diabetes, clinicians and researchers with better data and better insights, which ultimately can lead to better outcomes."

In their demand for cognitive applications, the partners are considering to include Watson- analyzed, ADA data. The aim of the challenge is to play a helpful role for the integration of the data into lives of persons with prediabetes or diabetes; it starts this summer. 

Beyond ADA and Medtronic, the AI system is also involved in a number of other diabetes ventures.

In 2015, data was presented by IBM Research on a predictive model to offer individualized ranks of risk factors of diabetes. And it just developed a research tie up with the Israel based HMO Maccabi for studying the prediction of diabetic retinopathy based on 2 decades of data for over than 2 million members.

In other news, the American cloud computing service provider has opened its IBM Watson center in Singapore. Mobile Health news has reported that the New York based company is also working with Medtroninc to help the cause of diabetes patients as the two organizations are working to use Watson's Cognitive computation abilities along with data from the medical tech development company to predict hyperglycemic -and hypo events and provide diabetes guidance and coaching to people for avoiding those events.